Clinical Trial

Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery

Study acronym: SASS

Recruiting Early Phase 1

Record status

This record was last updated October 8, 2024 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.

Summary

The goal of this pilot clinical trial is to test the feasibility of conducting a randomized controlled trial that will examine the use of ropivacaine in the spinal anesthesia for patients undergoing elective 1- or 2-level lower spine surgery. This study aims to: * Determine the rates of eligibility, recruitment, consent, and attrition * Determine the acceptability among patients, surgeons, anesthesiologists, and nurses of doing spine surgery under spinal anesthesia * Gather preliminary data on outcomes relevant to a future dose-finding study Participants will be randomized to one of three treatment groups: * General anesthesia with endotracheal tube * Spinal anesthesia with bupivacaine * Spinal anesthesia with ropivacaine

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2023-04-11; most recent amendment 2024-10-04.

Status change: Not Yet Recruiting → Recruiting 2024-10-04

Trial Details

NCT Number	NCT05824338
Lead Sponsor	Fraser Health
Conditions	Anesthesia, Spinal, Neurosurgery, Ropivacaine, Bupivacaine
Enrollment	45 participants
Start Date	2024-08-27
Primary Completion	2025-07-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-10-08